MGLU2 AGONISTS
The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
18.09.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder. |
---|---|
Bibliography: | Application Number: EP20100798419 |